These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12027573)
1. Low dose and slow titration of topiramate as adjunctive therapy in refractory partial epilepsies: a multicentre open clinical trial. Korian Topiramate Study Group Seizure; 2002 Jun; 11(4):255-60. PubMed ID: 12027573 [TBL] [Abstract][Full Text] [Related]
2. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group. Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342 [TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study. Cho YJ; Heo K; Kim WJ; Jang SH; Jung YH; Ye BS; Song DB; Lee BI Epilepsia; 2009 Aug; 50(8):1910-9. PubMed ID: 19563348 [TBL] [Abstract][Full Text] [Related]
4. A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387 [TBL] [Abstract][Full Text] [Related]
5. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy. Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B; Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865 [TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230 [TBL] [Abstract][Full Text] [Related]
7. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development. Sachdeo R; Partiot A; Biton V; Rosenfeld WE; Nohria V; Tompson D; DeRossett S; Porter RJ Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135 [TBL] [Abstract][Full Text] [Related]
9. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial. Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J; Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study. Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083 [TBL] [Abstract][Full Text] [Related]
12. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study. Ramsay RE; Uthman B; Pryor FM; Rowan AJ; Bainbridge J; Spitz M; Sirven JI; Frederick TE Epilepsia; 2008 Jul; 49(7):1180-5. PubMed ID: 18494791 [TBL] [Abstract][Full Text] [Related]
13. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy. Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B; Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062 [TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Tassinari CA; Michelucci R; Chauvel P; Chodkiewicz J; Shorvon S; Henriksen O; Dam M; Reife R; Pledger G; Karim R Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816 [TBL] [Abstract][Full Text] [Related]
15. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine. Majkowski J; Neto W; Wapenaar R; Van Oene J Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429 [TBL] [Abstract][Full Text] [Related]
16. Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates--an exploratory study. Kurth C; Schäuble B; Schreiner A; Rettig K; Steinhoff BJ Acta Neurol Scand; 2009 Aug; 120(2):80-7. PubMed ID: 19432934 [TBL] [Abstract][Full Text] [Related]
17. Topiramate: a new safe and effective antiepileptic. Gupta M; Rehman N; Bansal J; Mogre V J Indian Med Assoc; 2001 Aug; 99(8):449-50. PubMed ID: 11881861 [TBL] [Abstract][Full Text] [Related]
18. Add-on topiramate in the treatment of refractory partial-onset epilepsy: clinical experience of outpatient epilepsy clinics from 11 general hospitals. Giannakodimos ST; Georgiadis G; Tsounis ST; Triantafillou N; Kimiskidis V; Giatas K; Karlovasitou A; Mitsikostas DD; Thodi E; Polychronopoulos P; Ramopoulos N; Michailidis K; Michalis N; Garganis K; Gatzonis ST; Balogiannis ST; Kazis AR; Milonas J; Van Oene JC Seizure; 2005 Sep; 14(6):396-402. PubMed ID: 16019237 [TBL] [Abstract][Full Text] [Related]
19. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study. Baker GA; Currie NG; Light MJ; Schneiderman JH; Seizure; 2002 Jan; 11(1):6-15. PubMed ID: 11888254 [TBL] [Abstract][Full Text] [Related]
20. Topiramate in refractory epilepsy: a prospective observational study. Stephen LJ; Sills GJ; Brodie MJ Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]